CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | Hartley Lindsey Marie CFO | Option exercise | +5,000 | $8.20 | $41K | 45,763 |
| 2025-12-08 | Hartley Lindsey Marie CFO | Sale | −11,533 | $31.56 | $364K | 34,230 |
| 2025-12-08 | Hartley Lindsey Marie CFO | Sale | −2,854 | $31.56 | $90K | 31,376 |
| 2025-12-08 | Hartley Lindsey Marie CFO | Option exercise · Employee Stock Option (right to purchase) | −20,000 | 0 | ||
| 2025-12-08 | Hartley Lindsey Marie CFO | Option exercise · Employee Stock Option (right to purchase) | −5,000 | 2,500 | ||
| 2025-12-04 | Began Marc A EVP & General Counsel | Grant or award | +22,500 | 40,785 | ||
| 2025-12-04 | DeVinney Erick Wayne Chief Innovation Officer | Grant or award | +40,000 | 260,649 | ||
| 2025-12-04 | Kemp Jens Chief Marketing Officer | Grant or award | +22,500 | 54,186 | ||
| 2025-12-04 | DALE MICHAEL D Chief Executive Officer | Grant or award | +150,000 | 150,000 | ||
| 2025-11-11 | Burke William P. Mr. Director | Option exercise 10b5-1 | +3,591 | $8.14 | $29K | 3,691 |
| 2025-11-11 | Burke William P. Mr. Director | Sale 10b5-1 | −3,591 | $24.02 | $86K | 100 |
| 2025-11-11 | Burke William P. Mr. Director | Option exercise · Stock Option (right to purchase) 10b5-1 | −3,591 | 0 | ||
| 2025-11-10 | Burke William P. Mr. Director | Option exercise 10b5-1 | +19,227 | $8.14 | $157K | 19,327 |
| 2025-11-10 | Burke William P. Mr. Director | Sale 10b5-1 | −19,227 | $24.01 | $462K | 100 |
| 2025-11-10 | Burke William P. Mr. Director | Option exercise · Stock Option (right to purchase) 10b5-1 | −19,227 | 3,591 | ||
| 2025-11-06 | Burke William P. Mr. Director | Option exercise 10b5-1 | +5,347 | $8.14 | $44K | 5,447 |
| 2025-11-06 | Burke William P. Mr. Director | Sale 10b5-1 | −5,347 | $24.01 | $128K | 100 |
| 2025-11-06 | Burke William P. Mr. Director | Option exercise · Stock Option (right to purchase) 10b5-1 | −5,347 | 22,818 | ||
| 2025-11-05 | Burke William P. Mr. Director | Option exercise 10b5-1 | +11,431 | $8.14 | $93K | 11,531 |
| 2025-11-05 | Burke William P. Mr. Director | Sale 10b5-1 | −11,431 | $24.05 | $275K | 100 |
Page 7 of 61 · 1,220 trades